NCOR2 overexpression
|
Estrogen Receptor Positive Breast Cancer
|
NCOR2 overexpression
|
Estrogen Receptor Positive Breast Cancer
|
tamoxifen Resistant: C3 – Early Trials
|
tamoxifen Resistant: C3 – Early Trials
|
NCOR2 overexpression
|
Breast Cancer
|
NCOR2 overexpression
|
Breast Cancer
|
epirubicin Resistant: D – Preclinical
|
epirubicin Resistant: D – Preclinical
|